Skip to content
JournalsWorldThe Global Research Discovery Platform

Academic Journal

Q1

Therapeutic Advances in Psychopharmacology

United KingdomPharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)ISSN-matched source record
Q1Ranking
—Impact Factor (year unverified)
52H-index (SCImago 2025)
1.321SJR (2025)
2011-2026Coverage

About Therapeutic Advances in Psychopharmacology

Therapeutic Advances in Psychopharmacology is a scholarly journal published by SAGE Publications Inc.. SCImago 2025 lists it in Q1, with an SJR of 1.321 and H-index of 52.

Coverage: 2011-2026. Research categories: Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1).

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2024-04-04. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY, CC BY-NC
Peer-review processAnonymous peer review
APCDOAJ-reported APC: 2650 USD
Waiver policy reportedYes
Other fees reportedNo
Author retains unrestricted copyrightNo
Digital preservationCLOCKSS, LOCKSS, PMC, Portico
Reported submission-to-publication time10 weeks on average; not a guarantee
Openly licensed content since2019 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)2045-1253, 2045-1261
ISSN-L2045-1253
Source typeJournal
Publisher / hosting organisationSAGE Publishing
Publisher country codeGB
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex653
Citations recorded in OpenAlex16,514
OpenAlex H-index61
Years represented in OpenAlex1960–2026 (not the founding or closing dates)

Topics in published research

Schizophrenia research and treatment; Treatment of Major Depression; Bipolar Disorder and Treatment; Tryptophan and brain disorders; Electroconvulsive Therapy Studies; Healthcare Decision-Making and Restraints.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit